Search clinical trials for: Lantus

Total 666 results

Boston Scientific Corporation

Completed

REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System

Transcatheter Aortic Valve Replacement

Spain, United Kingdom, Australia, France, Germany, Italy, Netherlands, Sweden, Switzerland
Boston Scientific Corporation

Completed

REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm (REPRISE I)

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Calcification

Australia
Second Affiliated Hospital, School of Medicine,...

Unknown

Safety and Efficacy of Lotus Valve For TAVI In Patients With Severe Aortic Stenosis In Chinese Population (LOTUS-CHINA)

Aortic Valve Stenosis

China
Yonsei University

Unknown

Patient Satisfaction With Novel Double Pants Compared to Conventional Single Pants for Outpatient Colonoscopy

Colonoscopy

Korea, Republic of
Nova Scotia Health Authority

Withdrawn

FCR or APL in LRTI - A Single Surgeon Randomized Controlled Trial

Osteoarthritis
University of Washington

Completed

Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose (GLIDING)

Type 1 Diabetes

United States
Baylor College of Medicine

Completed

Lantus in the Treatment of Type 1 Diabetes Children

Type 1 Diabetes

United States
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients

Type2 Diabetes

India
University of New Mexico

Completed

Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes

Diabetes Mellitus

United States
Boston Scientific Corporation

Completed

Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement (REPRISE Japan)

Aortic Stenosis

Japan
Boston Scientific Corporation

Terminated

RESPOND EDGE Post Market Study (RESPOND EDGE)

Aortic Valve Stenosis

Denmark, United Kingdom, France, Netherlands, Ireland, Finland, Germany, Italy, Sweden
Thomas Jefferson University
University of Rochester

Not yet recruiting

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2) (START2)

Pregnancy Related | Gestational Diabetes

United States
Biologics & Biosimilars Collective Intelligence...
Merck Sharp & Dohme LLC; Pfizer; AbbVie; University of Pittsburgh; Boehringer Ingelheim and other collaborators

Completed

Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics

Diabetes
Cairo University

Completed

Comparison on Efficacy and Safety of Three Inpatient Insulin Therapy in Type2 DM

Diabetes Mellitus (DM)

Egypt
Federal University of Health Science of Porto Alegre
Douglas Haselstrom

Completed

Comparison of Muscle Activity in Exercise Bike and Elliptical Trainer in Individuals With Spinal Cord Injury

Spinal Cord Injury

Brazil
Emory University

Completed

Glargine U300 Hospital Trial

Type 2 Diabetes

United States
Third Affiliated Hospital, Sun Yat-Sen University
Guangdong Provincial Department of Science and Technology

Unknown

Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes (COGFOST)

Diabetes Mellitus, Type 2

China
The Whiteley Clinic
Bauerfeind

Recruiting

Study to Investigate the Influence of Compression Treatment in Patients With Pelvic Congestion Syndrome (PCS)

Pelvic Congestive Syndrome

United Kingdom
Boston Scientific Corporation

Terminated

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects (REPRISE IV)

Aortic Valve Stenosis

United States, Australia
Philips Healthcare
Memorial Hospital of South Bend

Withdrawn

Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB

Stress | Preterm Birth | Growth Acceleration | Chronic Lung Disease | Satisfaction | Adverse Event | Low; Birthweight, Extremely (999 Grams or Less) | Neonatal Infection

United States
Kimberly-Clark Corporation

Recruiting

Effect of Use of DryNites Absorbent Pants on the Rate of Spontaneous Resolution of Paediatric Nocturnal Enuresis (NE)

Nocturnal Enuresis

United Kingdom
Children's Hospital of Fudan University

Recruiting

The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics

Prader-Willi Syndrome

China
University of Florida
Lallemand Health Solutions

Completed

B. Lactis B94 Effects of Gastrointestinal Function

Quality of Life

United States
Ruhr University of Bochum

Unknown

Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus

Lichen Planus

Germany
Geropharm

Completed

A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients

Clamp Study

Russian Federation
Inova Health Care Services

Withdrawn

The Inova Type 2 Diabetes Mellitus Study (InovaDM2)

Diabetes, Type 2

United States
The Cleveland Clinic

Terminated

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

Type 1 Diabetes | Type 2 Diabetes | Diabetic Ketoacidosis

United States
Guillermo Umpierrez

Completed

Diabetes in the Elderly: Prospective Study (DMElderly)

Hyperglycemia | Diabetes

United States
Philips Healthcare
Children's Hospital and Medical Center, Omaha, Nebraska

Withdrawn

Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO

Stress | Preterm Birth | Growth Acceleration | Chronic Lung Disease | Satisfaction | Adverse Event | Low; Birthweight, Extremely (999 Grams or Less) | Neonatal Infection

United States
Boston Scientific Corporation

Terminated

REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System (REPRISE EDGE)

Aortic Valve Stenosis

Sweden, Denmark, France
Boston Scientific Corporation

Terminated

Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement (REPRISE III)

Aortic Stenosis

United States, Australia, Canada, France, Germany, Netherlands
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

New Onset Type 1 Diabetes: Role of Exenatide

Type 1 Diabetes

United States
Emory University
Boston Medical Center; Rush University; University of Denver

Completed

Linagliptin Inpatient Trial

Type 2 Diabetes

United States
Emory University
Merck Sharp & Dohme LLC; University of Michigan; Temple University; Ohio University

Completed

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

Type 2 Diabetes

United States
University of Michigan
Eli Lilly and Company; Amylin Pharmaceuticals, LLC.

Completed

Evaluation of Exenatide in Patients With Diabetic Neuropathy

Type 2 Diabetes Mellitus | Diabetic Peripheral Neuropathy

United States
Pfizer

Completed

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

Diabetes Mellitus, Type 2

United States
Charles Drew University of Medicine and Science
National Center for Research Resources (NCRR)

Terminated

Insulin Glargine Versus Twice-Daily NPH

Type 2 Diabetes Mellitus

United States
Sanofi

Completed

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)

Diabetes Mellitus

Brazil
Alcon Research

Completed

A Comparison of Visual Function After Bilateral Implantation of Presbyopia Correcting Intraocular Lenses

Cataract

Spain
Taipei Veterans General Hospital, Taiwan

Completed

Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control

Type 2 Diabetes

Taiwan
Sohag University

Recruiting

Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata

Alopecia Areata

Egypt
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Identification of Allergic Asthmatics Reactive to Felis Catus (Cat Hair) Allergen Inhalation

Asthma Atopic

United States
Novo Nordisk A/S

Completed

A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study (SWITCH PRO)

Diabetes Mellitus, Type 2

United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
Sanofi

Completed

Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine (SORELLA1)

Type 1 Diabetes Mellitus

Japan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
HealthPartners Institute
Sanofi; International Diabetes Center at Park Nicollet

Completed

Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine

Type 2 Diabetes

United States
Sanofi

Completed

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus (EDITION IV)

Type 1 Diabetes Mellitus

United States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
Chongqing Medical University

Completed

Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 Diabetes

Diabetes

China
Cairo University
Sanofi

Unknown

Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial (VIRDICT)

Liver Cirrhosis | Type 2 Diabetes

Egypt
Adocia
Tonghua Dongbao Pharmaceutical Co.,Ltd

Completed

A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes

Type 1 Diabetes

Germany
Colorado State University

Completed

BacterioPHAGE for Gastrointestinal Health 2 Study (PHAGE2)

Mild Gastrointestinal Symptoms in Healthy Adults

United States

Search clinical trials for: Lantus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations